http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Drugs on the Horizon for Colorectal Cancer
Cardin, D. B.; Berlin, J. D. Springer Science + Business Media 2011 p.191-199
Zoccali, M.; Krane, M.; Fichera, A. Springer Science + Business Media 2011 p.200-210
Why Cetuximab is Not Active in the Adjuvant Setting
Murray, J. C.; Wu, C. S.; Weiner, L. M. Springer Science + Business Media 2011 p.211-217
Should We Perform a New Adjuvant Trial with Bevacizumab?
Dasari, A.; Messersmith, W. A. Springer Science + Business Media 2011 p.218-226
Biological Markers in Patients with Early-Stage Colon Cancer: Consensus and Controversies
Field, K. M.; Zalcberg, J. R. Springer Science + Business Media 2011 p.227-240
Reduced Chemotherapy Duration: A Good Idea?
Hubbard, J.; Grothey, A. Springer Science + Business Media 2011 p.241-245
Is There a Future for Bevacizumab in the Adjuvant Setting After the C-08 and AVANT Trials?
Riechelmann, R. P.; Hoff, P. M.; Capareli-Azevedo, F.; Gramont, A. Springer Science + Business Media 2011 p.246-251